Tuning hERG Out: Antitarget QSAR Models for Drug Development

E-ISSN： 1873-4294|14|11|1399-1415

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.11, 2014-01, pp. : 1399-1415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The hERG channel as target and anti-target

By Lamers Christina Schubert-Zsilavecz Manfred

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 337-343

Govi-Verlag

Access to resources Recommend Favorite

hERG-related drug toxicity and models for predicting hERG liability and QT prolongation

By Raschi Emanuel Ceccarini Luisa De Ponti Fabrizio Recanatini Maurizio

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1005-1021

Informa Healthcare

Access to resources Recommend Favorite

Molecular mechanisms for drug interactions with hERG that cause long QT syndrome

By Stansfeld Phillip J Sutcliffe Michael J Mitcheson John S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 1, 2006-02 ,pp. : 81-94

Informa Healthcare

Access to resources Recommend Favorite

The hERG Channel and Risk of Drug-Acquired Cardiac Arrhythmia: An Overview

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 13, 2008-09 ,pp. : 1102-1112

Bentham Science Publishers

Access to resources Recommend Favorite

Predictive Models for hERG Channel Blockers: Ligand-Based and Structure-Based Approaches

Current Medicinal Chemistry, Vol. 14, Iss. 28, 2007-12 ,pp. : 3003-3026

Bentham Science Publishers

Access to resources Recommend Favorite